Gaviscon For The Treatment Of Heartburn Attributable To Gastroesophageal Reflux Disease


S.A. Bulgakov

The article is dedicated to the causes and mechanisms of development of gastroesophageal reflux disease (GERD) and its symptoms, primarily heartburn. Data for epidemiological analysis of the prevalence of GERD and heartburn in our country are demonstrated; main options for treatment of GERD are presented. Among the drugs, special attention is given to Gaviscon, which is based on sodium alginate. The main mechanisms of action of Gaviscon, which are different from mechanisms of action of “classical” antacids, are described. Information about the effectiveness of Gaviscon in the treatment of GERD and its manifestations, and recommendations for its use in treatment of diseases of the upper gastrointestinal tract are presented.

Similar Articles


Бионика Медиа